Facebook
Twitter
LinkedIn
ForwardSafe Opioid Prescribing for Pediatric Patients
This course has been approved by the Wisconsin Medical Examining Board as meeting the requirements for a continuing education course on the responsible opioid prescribing guidelines per Med 13.03(3) of the Wisconsin Administrative Code
COURSE OVERVIEW
This interactive course addresses minimizing opioid use and safe opioid prescribing for pediatric patients. Participants have multiple opportunities to engage in learning by viewing presentations, working with the clinical cases and receiving immediate feedback, and studying provided educational resources.
PRACTICE GAPS AND NEEDS
There is great variation among pediatric providers in opioid prescribing based on patient-specific demographic characteristics and pain-related diagnoses. Research indicates that many opioid prescriptions dispensed to pediatric patients include more opioids than are needed to treat the acute pain disorder. The rate of total pediatric admissions and PICU admissions related to opioid ingestion have increased significantly in the last twenty years in US children’s hospitals. The mortality rate among children and adolescents because of prescription and illicit opioid poisonings have increased, too. Clinical teams are challenged to respond to a growing public health problem in the young related to opioid use.
ELEMENTS OF COMPETENCE
This activity changes learner competence and focuses on these elements:
- American Board of Medical Specialties: Medical knowledge, and interpersonal and communication skills
- Interprofessional Education Collaborative: Roles/responsibilities, interprofessional communication, and teams and teamwork
Intended Audience
Pediatricians, physician assistants, nurse practitioners, nurses, pharmacists, social workers, and other healthcare providers who provide care to pediatric patients.
Learning Objectives
As a result of participation in this course, participants will improve ability to:
- Use best practice for safe opioid selection, dosing, duration, and discontinuation in pediatric patients
- Apply techniques to minimize opioid use in pediatric population
- Effectively communicate with patients and families to support safe use, storage, and disposal of prescribed opioids
- Discuss innovative practices for collaborative, patient-centered pain management in pediatric care
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.
For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
Disclosure of Unlabeled Use: The University of Wisconsin–Madison ICEP advises the participant that this continuing medical education activity does NOT contain reference(s) to unlabeled or unapproved uses of drugs or devices.
Clinical Directors/Planning Committee Chairs | ||||
| Financial Relationship Disclosure | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? | |||
Benjamin Walker | MD | Reviewer; Associate Professor, Department of Anesthesiology at University of Wisconsin School of Medicine and Public Health; Director of Pediatric Pain Management at American Family Children's Hospital | No relevant financial relationships with ineligible companies to disclose | No |
Blaise Nemeth | MD, MS | Reviewer; Associate Professor (CHS), Department of Orthopedics and Rehabilitation at University of Wisconsin School of Medicine and Public Health | No relevant financial relationships with ineligible companies to disclose | No |
| Peggy Riley | RN, MN, MPH | Activity Chair; Program Director, Pediatric Pain and Pediatric Palliative Care Programs at American Family Children’s Hospital/UW Health | No relevant financial relationships with ineligible companies to disclose | No |
Additional Committee Members | ||||
Hanna Christensen | PharmD, BCPPS | Pediatric Clinical Pharmacist at American Family Children’s Hospital, University of Wisconsin Hospital and Clinics | No relevant financial relationships with ineligible companies to disclose | No |
Michael Kim | MD | Associate Professor, BerbeeWalsh Department of Emergency Medicine and Pediatrics at University of Wisconsin School of Medicine and Public Health | No relevant financial relationships with ineligible companies to disclose | No |
Amy Plumb | MD | Associate Professor (CHS), Department of Pediatrics at University of Wisconsin School of Medicine and Public Health | No relevant financial relationships with ineligible companies to disclose | No |
Ryan Seagren | PharmD, BCPPS | Pediatric Clinical Pharmacist at American Family Children’s Hospital, University of Wisconsin Hospitals and Clinics | No relevant financial relationships with ineligible companies to disclose | No |
Jessica A. Stafford Draper | MSN, RN, CPNP | Pediatric Trauma Nurse Practitioner at American Family Children's Hospital, University of Wisconsin Hospitals and Clinics | No relevant financial relationships with ineligible companies to disclose | No |
Accreditation Statement
 | In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
Credit Designation Statements
Accreditation Council for Pharmacy Education (ACPE)
A maximum of 2 hours of knowledge-based CE credit can be earned by successfully completing this material. Pharmacists should claim only the credit commensurate with the extent of their participation in the material. CE credit information, based on verification of live attendance and completion of the program assessment and evaluation, will be provided to NABP within 60 days after the activity completion.
Universal Activity Number: JA0000358-0000-22-060-H01-P
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this enduring material for a maximum of 2 ANCC contact hours, 2 of which are eligible for pharmacotherapeutic contact hours.
American Psychological Association (APA)
 | Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibly for the content of the programs. |
American Board of Pediatrics MOC Credit
Successful completion of this CME material, which includes participation in the activity and individual assessment of and feedback to the learner, enables the learner to earn up to 2.0 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.
Continuing Education Units
The University of Wisconsin–Madison, as a member of the University Continuing Education Association (UCEA), authorizes this program for 0.2 continuing education units (CEUs) or 2 hours.
Wisconsin Medical Examining Board Opioid CME
This course has been approved by the Wisconsin Medical Examining Board as meeting the requirements for a continuing education course on the responsible opioid prescribing guidelines per Med 13.03(3) of the Wisconsin Administrative Code.
Course title: Safe Opioid Prescribing for Pediatric Patients
The following instructors have been approved for your course: Various
Number of Credits Approved: 2
Ref #: MEB-1089
Available Credit
- 2.00 MOC: ABP Lifelong Learning Points (Part II)
- 2.00 ACPE Contact Hours - Pharmacist
- 2.00 Wisconsin Responsible Opioid Prescribing Credit
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Wisconsin Responsible Opioid Prescribing Credit
- 2.00 ANCC Contact Hours
- 2.00 Wisconsin Responsible Opioid Prescribing Credit
- 2.00 ANCC Pharmacotherapy Contact Hours
- 2.00 APA CE Credits
- 2.00 University of Wisconsin–Madison Continuing Education Hours
- 2.00 Approved for AMA PRA Category 1 Credit™
- 2.00 Wisconsin Responsible Opioid Prescribing Credit
Cost:
UW and affiliates: FREE
Others: $50
If you are UW-Madison or affiliate and do not see a cost of $0 and feel this is in error, please contact help@icep.wisc.edu.
Required Hardware/software
Free, current version of Chrome, Firefox, Safari, or Microsoft Edge. Some older browsers and Internet Explorer could produce error messages or not display the content correctly.
Free, current version of Adobe Acrobat Reader or other .pdf reader